An inexpensive drug already in use for other diseases might hold the key to a completely new way of treating cancers -- not by killing off cancer cells, but by simply reprogramming them.
How exciting to read about Canadian research. The drug is called
No drug company holds the patent in dichloroacetate (DCA), as it is an 'orphan drug'.
Totally funded by patient donations, charity groups and government agencies.
Studying only 5 patients, the findings are only 'proof in principle'. Cancer cells are agressive. They are voracious and require a lot of nutritent. They suppress mitochondria, the part of the cell that converts food into energy, and can kill off surrounding cells if they need too much energy. Good news, indeed!